A Pilot Study of the Efficacy and Safety of Paroxetine Augmented With Risperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in Adult Chinese Patients With Treatment-Resistant Major Depression

Trial Profile

A Pilot Study of the Efficacy and Safety of Paroxetine Augmented With Risperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in Adult Chinese Patients With Treatment-Resistant Major Depression

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2011

At a glance

  • Drugs Mirtazapine (Primary) ; Paroxetine (Primary) ; Venlafaxine (Primary) ; Buspirone; Risperidone; Thyroid hormones; Trazodone; Valproic acid
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms OPERATION
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top